Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-interleukin-2 receptor subunit gamma monoclonal antibody REGN7257

A monoclonal antibody targeted against interleukin-2 (IL-2) receptor subunit gamma (IL2RG; CD132; cytokine receptor common subunit gamma; gamma chain; gc), with potential immunomodulatory activity. Upon administration, anti-IL2RG monoclonal antibody REGN7257 targets and binds to the gamma subunit of the human IL-2 receptor (IL-2R) expressed on the surface of activated T lymphocytes, thereby inhibiting IL-2 binding and IL-2-mediated T-cell activation. This may block T-cell-mediated immune responses. IL2RG plays a role in both immune responses and interleukin signaling.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-cytokine receptor common subunit gamma monoclonal antibody REGN7257
anti-gamma chain receptor monoclonal antibody REGN7257
anti-IL2RG monoclonal antibody REGN7257
Code name:REGN 7257
REGN-7257
REGN7257
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search